For: | Ohno M, Otsuka M, Kishikawa T, Yoshikawa T, Takata A, Koike K. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA. World J Gastroenterol 2015; 21(23): 7084-7088 [PMID: 26109795 DOI: 10.3748/wjg.v21.i23.7084] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i23/7084.htm |
Number | Citing Articles |
1 |
Frank Buchholz, Joachim Hauber. Antiviral therapy of persistent viral infection using genome editing. Current Opinion in Virology 2016; 20: 85 doi: 10.1016/j.coviro.2016.09.012
|
2 |
Lung-Yi Mak, Wai-Kay Seto, James Fung, Man-Fung Yuen. Novel developments of hepatitis B: treatment goals, agents and monitoring tools. Expert Review of Clinical Pharmacology 2019; 12(2): 109 doi: 10.1080/17512433.2019.1567327
|
3 |
Kazuma Sekiba, Motoyuki Otsuka, Motoko Ohno, Mari Yamagami, Takahiro Kishikawa, Tatsunori Suzuki, Rei Ishibashi, Takahiro Seimiya, Eri Tanaka, Kazuhiko Koike. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA. World Journal of Gastroenterology 2018; 24(21): 2261-2268 doi: 10.3748/wjg.v24.i21.2261
|
4 |
Thuy Thi Bich Phung, Son Van Chu, Son Thien Vu, Hanh Thi Pham, Hang Minh Nguyen, Hoan Dang Nguyen, Ngan Thi Le, Dung Van Nguyen, Phuong Thai Truong, Van Thi Tuong Vu, Anh Thi Van Nguyen. COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B. Diagnostics 2020; 10(7): 491 doi: 10.3390/diagnostics10070491
|
5 |
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses. World Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
|
6 |
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish. Drugs in Development for Hepatitis B. Drugs 2017; 77(12): 1263 doi: 10.1007/s40265-017-0769-2
|
7 |
Sajad Ahmad Bhat, Syed Naqui Kazim. HBV cccDNA─A Culprit and Stumbling Block for the Hepatitis B Virus Infection: Its Presence in Hepatocytes Perplexed the Possible Mission for a Functional Cure. ACS Omega 2022; 7(28): 24066 doi: 10.1021/acsomega.2c02216
|
8 |
Ruiting Li, Qin Wang, Kaiqin She, Fang Lu, Yang Yang. CRISPR/Cas systems usher in a new era of disease treatment and diagnosis. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00095-y
|
9 |
Cheng Peng, Mengji Lu, Dongliang Yang. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV. Virologica Sinica 2015; 30(5): 317 doi: 10.1007/s12250-015-3660-x
|
10 |
Kunihiro Hasegawa, Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Ryo Takata, Kazunori Yoh, Noriko Ishii, Yukihisa Yuri, Takashi Nishimura, Hiroko Iijima, Etsuro Hatano, Jiro Fujimoto, Shuhei Nishiguchi. Proposed model for the prediction of intrahepatic covalently closed circular DNA level in patients with chronic hepatitis B. Hepatology Research 2019; 49(3): 271 doi: 10.1111/hepr.13280
|
11 |
Sema Alacam, Nuran Karabulut, Ayfer Yolcu, Mustafa Onel, Alp Atasoy, Sabahattin Kaymakoglu, Ali Agacfidan. Evaluation of drug resistance mutations in patients with chronic hepatitis B. Folia Microbiologica 2019; 64(2): 237 doi: 10.1007/s12223-018-0650-z
|
12 |
Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine. Critical Updates on Chronic Hepatitis B Virus Infection in 2021. Cureus 2021; doi: 10.7759/cureus.19152
|
13 |
Kazuto Tajiri, Yukihiro Shimizu. New horizon for radical cure of chronic hepatitis B virus infection. World Journal of Hepatology 2016; 8(21): 863-873 doi: 10.4254/wjh.v8.i21.863
|
14 |
Dhwani Rana, Arvee Prajapati, Bharathi Karunakaran, Lalitkumar Vora, Derajram Benival, Anil B. Jindal, Rikin Patel, Vishvesh Joshi, Ashutosh Jamloki, Ujashkumar Shah. Recent Advances in Antiviral Drug Delivery Strategies. AAPS PharmSciTech 2025; 26(3) doi: 10.1208/s12249-025-03053-3
|